Medullary cystic kidney disease with hyperuricemia and gout in a large Cypriot family: No allelism with nephronophthisis type 1

被引:0
|
作者
Stavrou, C
Pierides, A
Zouvani, I
Kyriacou, K
Antignac, C
Neophytou, P
Christodoulou, K
Deltas, CC
机构
[1] Cyprus Inst Neurol & Genet, Dept Mol Genet, CY-1683 Nicosia, Cyprus
[2] Minist Hlth, Dept Nephrol, Nicosia, Cyprus
[3] Nicosia Gen Hosp, Dept Histopathol, Nicosia, Cyprus
[4] Cyprus Inst Neurol & Genet, Dept Electron Microscopy, CY-1683 Nicosia, Cyprus
[5] Hop Necker Enfants Malad, Paris, France
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1998年 / 77卷 / 02期
关键词
medullary cystic disease; autosomal dominant; renal cysts; gout; hyperuricemia; adult onset; linkage analysis;
D O I
10.1002/(SICI)1096-8628(19980501)77:2<149::AID-AJMG8>3.0.CO;2-N
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We describe a large Cypriot family with an interstitial type of nephropathy, inherited as an autosomal dominant trait that led to end stage renal failure between 51 to 78 years of age (mean 62.2 years), Twenty-three people are known to be affected, but several younger relatives with normal renal function may remain undiagnosed because of the absence of precise clinical and laboratory diagnostic criteria. This nephropathy is associated with medullary renal cysts, hypertension, hyperuricemia, and gout. Several relatives have typical medullary cystic disease (MCD), while in the others the findings are compatible with this diagnosis. Due to the similarity of clinical and pathologic findings, earlier reports had suggested that MCD may be allelic to autosomal recessive familial juvenile nephronophthisis, which was mapped recently to chromosome band 2q13. Linkage analysis of the present family with a closely linked marker excluded linkage to the above locus. Linkage was also excluded to the PKD1 locus of adult polycystic kidney disease type 1, and up to 5 cM on either side, on chromosome 16, We suggest that because of the element of hyperuricemia and gout found in this family, although with reduced penetrance, it may represent a variant of autosomal dominant MCD of the adult type, This variability may be the result of allelic or locus heterogeneity. Molecular genetic approaches including linkage analysis on appropriate families will certainly assist in classifying such related genetically heterogeneous disorders. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 50 条
  • [31] IDENTIFICATION AND FUNCTIONAL STUDY OF A HETEROZYGOUS MISSENSE MUTATION IN UMOD GENE IN AN ITALIAN FAMILY AFFECTED BY MEDULLARY CYSTIC KIDNEY DISEASE TYPE II
    La Russa, Antonella
    Vizza, Donatella
    Bonofiglio, Martina
    Perri, Anna
    Toteda, Giuseppina
    Lupinacci, Simona
    Leone, Francesca
    Gigliotti, Paolo
    Lofaro, Danilo
    Bonofiglio, Renzo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [32] Chromosome 1 localization of a gene for autosomal dominant medullary cystic kidney disease (ADMCKD)
    Christodoulou, K
    Tsingis, M
    Stavrou, C
    Eleftheriou, A
    Papapavlou, P
    Patsalis, PC
    Ioannou, P
    Pierides, A
    Deltas, CC
    HUMAN MOLECULAR GENETICS, 1998, 7 (05) : 905 - 911
  • [33] Novel NPR1 polymorphic variants and its exclusion as a candidate gene for medullary cystic kidney disease (ADMCKD) type 1
    Koptides, M
    Mean, R
    Stavrou, C
    Pierides, A
    Demetriou, K
    Nakayama, T
    Hildebrandt, F
    Fuchshuber, A
    Deltas, CC
    MOLECULAR AND CELLULAR PROBES, 2001, 15 (06) : 357 - 361
  • [34] A NOVEL COL4A1 FRAMESHIFT MUTATION AND KIDNEY DISEASE WITHOUT EXTRA-RENAL INVOLVEMENT IN A LARGE TURKISH CYPRIOT FAMILY
    Gale, Daniel P.
    Oygar, Deren D.
    Lin, Fujun
    Oygar, Diren P.
    Connor, Thomas M. F.
    Khan, Nadia
    Lapsley, Marta
    Maxwell, Patrick H.
    Neild, Guy H.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [35] Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome neurofibromatosis association
    Bahuau, M
    Flintoff, W
    Assouline, B
    Lyonnet, S
    LeMerrer, M
    Prieur, M
    GuilloudBataille, M
    Feingold, N
    Munnich, A
    Vidaud, M
    Vidaud, D
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 66 (03): : 347 - 355
  • [36] Clinical characterization of a family with familial juvenile hyperuricemic nephropathy (FJHN) (or medullary cystic kidney disease) by haplotype analysis.
    Bleyer, AJ
    Hart, TC
    Zhu, HP
    Woodard, AS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 131A - 131A
  • [37] Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: Two facets of the same disease?
    Dahan, K
    Fuchshuber, A
    Adamis, S
    Smaers, M
    Kroiss, S
    Loute, G
    Cosyns, JP
    Hildebrandt, F
    Verellen-Dumoulin, C
    Pirson, Y
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (11): : 2348 - 2357
  • [38] Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease?
    Dahan, KS
    Fuchshuber, A
    Adamis, S
    Smaers, M
    Kroiss, S
    Loute, G
    Cosyns, JP
    Hildebrandt, F
    Verellen-Dumoulin, C
    Pirson, Y
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 305 - 305
  • [39] Analysis of a large family with the second type of autosomal dominant polycystic kidney disease
    Veldhuisen, B
    Breuning, MH
    WesbyvanSwaay, E
    Boersma, J
    Peters, DJM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 13 - 17
  • [40] Refinement of the gene locus for autosomal dominant medullary cystic kidney disease type 1 (MCKD1) and construction of a physical and partial transcriptional map of the region
    Fuchshuber, A
    Kroiss, S
    Karle, S
    Berthold, S
    Huck, K
    Burton, C
    Rahman, N
    Koptides, M
    Deltas, C
    Otto, E
    Rüschendorf, F
    Feest, T
    Hildebrandt, F
    GENOMICS, 2001, 72 (03) : 278 - 284